Have you been trying to get pregnant without success? You may qualify for one of our studies:
Diagnosis & Treatment of Sperm DNA Damage
We are recruiting patients for a new study to assess male fertility potential! The study will evaluate whether a dietary supplement can reduce DNA damage in sperm cells.
Possible candidates will include male patients' greater than 35 years old who are seeking treatment for infertility with his partner at Abington Reproductive Medicine and who is a candidate for an IUI, IVF or IVF-ICSI (excluding donor egg) procedure.
Additional Inclusion Criteria:
• Males must have greater than 30% sperm DNA fragmentation index as reported by initial SCSA diagnosis
• Males already taking supplements must stop taking them for at least 12 weeks before the qualify for the study.
Contact Charlene Murdoch, RNC-OB for more information at: 267-620-1525
Female Subjects with Primary Amenorrhea with Hypogonadotropic Hypogonadism
We are recruiting patients for a study for the LutrePulse Clinical Research Study. This study is for women between the ages of 18-40 who have been diagnosed with primary amenorrhea with hypogonadotropic hypogonadism, and have a desire to become pregnant. To lean more contact Charlene at: 267-620-1525.
The wonders of science find true meaning at Abington Reproductive Medicine. Our patients benefit from the latest in infertility research and techniques. Several of these advanced techniques have been pioneered and perfected through our ongoing research studies.
For more information about our studies, please call Charlene Murdoch, RNC-OB, Clinical Research Coordinator at: 267-620-1525.